US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist
  • 0.5937
  • +0.0001+0.02%
Trading Apr 16 10:11 ET
71.07MMarket Cap-0.46P/E (TTM)
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Feb 20 20:02
    NEWS
    $Unicycive Therapeutics (UNCY.US)$
    Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between Oxylanthanum Carbonate and Tenapanor in American Society of Nephrology Journal Kidney360
    Thursday, 20th February at 7:00 am
    LOS ALTOS, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced the publication of preclinical data desc...
    Jaguar8
    Jaguar8
    Jan 28 20:07
    NEWS
    $Unicycive Therapeutics (UNCY.US)$
    Unicycive Therapeutics Announces the Publication of Patient Perspectives on Phosphate Management in the Journal of Nephrological Science
    7 minutes ago, 4:00 AM PST
    Via GlobeNewswire
    UNCY
    Share
    LOS ALTOS, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the "Company" or "Unicycive"), today announced the publication of a review on ...
    Jaguar8
    Jaguar8
    Jan 7 21:26
    NEWS
    $Unicycive Therapeutics (UNCY.US)$
    Unicycive Therapeutics Announces Publication of Positive Oxylanthanum Carbonate (OLC) Dose Escalation Data in Clinical and Translational Science
    Tuesday, 7th January at 7:00 am
    LOS ALTOS, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the "Company" or "Unicycive"), today announced that data from the Company's oxylanthanum carb...
    Tyler R Mills
    Tyler R Mills
    Dec 19, 2024 04:49
    $Unicycive Therapeutics (UNCY.US)$can we just see green for o ce! its been two weeks !!!!!!
    Jaguar8
    Jaguar8
    Dec 17, 2024 20:38
    NEWS
    $Unicycive Therapeutics (UNCY.US)$
    Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics
    Tuesday, 17th December at 7:00 am
    LOS ALTOS, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the "Company" or "Unicycive"), today announced that data from the Company's oxylanthanum carbonate (OLC)...
Read more

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.010
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.370
Precision Drilling
PDS
43.345
4
Ermenegildo Zegna NV
ZGN
6.940
5
eBay
EBAY
66.360
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Trump's comeback to the Office

Following Trump's Policies to Seek Investment Opportunities

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀